GO:0005654 | nucleoplasm | 1.29e-06 | 1.86e-02 | 3.222 | 7 | 64 | 1082 |
GO:0044822 | poly(A) RNA binding | 2.47e-05 | 3.56e-01 | 3.035 | 6 | 50 | 1056 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 3.36e-05 | 4.85e-01 | 7.794 | 2 | 2 | 13 |
GO:0010467 | gene expression | 4.39e-05 | 6.33e-01 | 3.430 | 5 | 45 | 669 |
GO:0035329 | hippo signaling | 1.39e-04 | 1.00e+00 | 6.794 | 2 | 5 | 26 |
GO:0000398 | mRNA splicing, via spliceosome | 1.63e-04 | 1.00e+00 | 4.722 | 3 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-04 | 1.00e+00 | 4.687 | 3 | 17 | 168 |
GO:0005829 | cytosol | 3.39e-04 | 1.00e+00 | 2.016 | 7 | 86 | 2496 |
GO:0008380 | RNA splicing | 4.31e-04 | 1.00e+00 | 4.246 | 3 | 22 | 228 |
GO:0008134 | transcription factor binding | 5.13e-04 | 1.00e+00 | 4.160 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0006396 | RNA processing | 7.25e-04 | 1.00e+00 | 5.612 | 2 | 5 | 59 |
GO:0060242 | contact inhibition | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0003723 | RNA binding | 1.40e-03 | 1.00e+00 | 3.661 | 3 | 18 | 342 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.53e-03 | 1.00e+00 | 5.068 | 2 | 8 | 86 |
GO:0003157 | endocardium development | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0060215 | primitive hemopoiesis | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0005515 | protein binding | 2.41e-03 | 1.00e+00 | 1.108 | 9 | 198 | 6024 |
GO:0030529 | ribonucleoprotein complex | 2.58e-03 | 1.00e+00 | 4.687 | 2 | 5 | 112 |
GO:0007021 | tubulin complex assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0097167 | circadian regulation of translation | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0006355 | regulation of transcription, DNA-templated | 3.40e-03 | 1.00e+00 | 2.533 | 4 | 43 | 997 |
GO:0001714 | endodermal cell fate specification | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 2 | 5 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 |
GO:0042981 | regulation of apoptotic process | 4.58e-03 | 1.00e+00 | 4.265 | 2 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 4.64e-03 | 1.00e+00 | 4.256 | 2 | 7 | 151 |
GO:0010466 | negative regulation of peptidase activity | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 8 |
GO:0001955 | blood vessel maturation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0097284 | hepatocyte apoptotic process | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 9 |
GO:0003714 | transcription corepressor activity | 6.39e-03 | 1.00e+00 | 4.018 | 2 | 11 | 178 |
GO:0002199 | zona pellucida receptor complex | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 2 | 10 |
GO:0001841 | neural tube formation | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 1 | 10 |
GO:0046621 | negative regulation of organ growth | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 |
GO:0042162 | telomeric DNA binding | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 4 | 11 |
GO:0005838 | proteasome regulatory particle | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 13 |
GO:0043488 | regulation of mRNA stability | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 |
GO:0006401 | RNA catabolic process | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 14 |
GO:0000242 | pericentriolar material | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 14 |
GO:0043539 | protein serine/threonine kinase activator activity | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 14 |
GO:0016071 | mRNA metabolic process | 9.87e-03 | 1.00e+00 | 3.693 | 2 | 8 | 223 |
GO:0001824 | blastocyst development | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 15 |
GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 17 |
GO:0016070 | RNA metabolic process | 1.20e-02 | 1.00e+00 | 3.546 | 2 | 8 | 247 |
GO:0045861 | negative regulation of proteolysis | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 4 | 18 |
GO:0000166 | nucleotide binding | 1.31e-02 | 1.00e+00 | 3.477 | 2 | 13 | 259 |
GO:0032757 | positive regulation of interleukin-8 production | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 20 |
GO:0005720 | nuclear heterochromatin | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 22 |
GO:0004869 | cysteine-type endopeptidase inhibitor activity | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 2 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0007339 | binding of sperm to zona pellucida | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 2 | 25 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 26 |
GO:0004866 | endopeptidase inhibitor activity | 1.99e-02 | 1.00e+00 | 5.636 | 1 | 3 | 29 |
GO:0001569 | patterning of blood vessels | 2.13e-02 | 1.00e+00 | 5.540 | 1 | 1 | 31 |
GO:0042594 | response to starvation | 2.13e-02 | 1.00e+00 | 5.540 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 32 |
GO:0045600 | positive regulation of fat cell differentiation | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 32 |
GO:0043565 | sequence-specific DNA binding | 2.27e-02 | 1.00e+00 | 3.060 | 2 | 11 | 346 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 5 | 37 |
GO:0042752 | regulation of circadian rhythm | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 3 | 37 |
GO:0032092 | positive regulation of protein binding | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 2 | 38 |
GO:0035019 | somatic stem cell maintenance | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 2 | 42 |
GO:0045727 | positive regulation of translation | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 2 | 44 |
GO:0008344 | adult locomotory behavior | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 2 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 4 | 46 |
GO:0044297 | cell body | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 2 | 46 |
GO:0030216 | keratinocyte differentiation | 3.21e-02 | 1.00e+00 | 4.940 | 1 | 2 | 47 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.25e-02 | 1.00e+00 | 2.783 | 2 | 30 | 419 |
GO:0000902 | cell morphogenesis | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 4 | 49 |
GO:0001669 | acrosomal vesicle | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 2 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 5 | 52 |
GO:0000502 | proteasome complex | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 3 | 58 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.02e-02 | 1.00e+00 | 4.612 | 1 | 6 | 59 |
GO:0044267 | cellular protein metabolic process | 4.07e-02 | 1.00e+00 | 2.605 | 2 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.14e-02 | 1.00e+00 | 2.593 | 2 | 24 | 478 |
GO:0006406 | mRNA export from nucleus | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 2 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 2 | 65 |
GO:0003677 | DNA binding | 4.60e-02 | 1.00e+00 | 1.829 | 3 | 49 | 1218 |
GO:0010468 | regulation of gene expression | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 2 | 68 |
GO:0018105 | peptidyl-serine phosphorylation | 4.68e-02 | 1.00e+00 | 4.386 | 1 | 2 | 69 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 2 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 2 | 74 |
GO:0002020 | protease binding | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 7 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 2 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 2 | 79 |
GO:0005524 | ATP binding | 5.40e-02 | 1.00e+00 | 1.737 | 3 | 31 | 1298 |
GO:0006915 | apoptotic process | 5.42e-02 | 1.00e+00 | 2.378 | 2 | 12 | 555 |
GO:0009653 | anatomical structure morphogenesis | 5.61e-02 | 1.00e+00 | 4.119 | 1 | 2 | 83 |
GO:0005634 | nucleus | 6.02e-02 | 1.00e+00 | 0.925 | 6 | 159 | 4559 |
GO:0001649 | osteoblast differentiation | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 1 | 92 |
GO:0005770 | late endosome | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 2 | 93 |
GO:0051082 | unfolded protein binding | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 7 | 93 |
GO:0007417 | central nervous system development | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 5 | 96 |
GO:0070062 | extracellular vesicular exosome | 6.93e-02 | 1.00e+00 | 1.265 | 4 | 57 | 2400 |
GO:0010951 | negative regulation of endopeptidase activity | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 6 | 104 |
GO:0000209 | protein polyubiquitination | 7.76e-02 | 1.00e+00 | 3.636 | 1 | 3 | 116 |
GO:0046983 | protein dimerization activity | 7.89e-02 | 1.00e+00 | 3.612 | 1 | 5 | 118 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 8.15e-02 | 1.00e+00 | 2.045 | 2 | 39 | 699 |
GO:0007050 | cell cycle arrest | 8.27e-02 | 1.00e+00 | 3.540 | 1 | 5 | 124 |
GO:0016055 | Wnt signaling pathway | 9.17e-02 | 1.00e+00 | 3.386 | 1 | 4 | 138 |
GO:0005737 | cytoplasm | 9.18e-02 | 1.00e+00 | 0.937 | 5 | 124 | 3767 |
GO:0006457 | protein folding | 9.49e-02 | 1.00e+00 | 3.334 | 1 | 7 | 143 |
GO:0000082 | G1/S transition of mitotic cell cycle | 9.87e-02 | 1.00e+00 | 3.275 | 1 | 3 | 149 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.00e-01 | 1.00e+00 | 1.870 | 2 | 41 | 789 |
GO:0046777 | protein autophosphorylation | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 4 | 158 |
GO:0000287 | magnesium ion binding | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 4 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 2 | 171 |
GO:0016607 | nuclear speck | 1.13e-01 | 1.00e+00 | 3.068 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.17e-01 | 1.00e+00 | 3.018 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 22 | 184 |
GO:0003713 | transcription coactivator activity | 1.53e-01 | 1.00e+00 | 2.605 | 1 | 24 | 237 |
GO:0005874 | microtubule | 1.60e-01 | 1.00e+00 | 2.534 | 1 | 7 | 249 |
GO:0043065 | positive regulation of apoptotic process | 1.71e-01 | 1.00e+00 | 2.428 | 1 | 7 | 268 |
GO:0035556 | intracellular signal transduction | 1.91e-01 | 1.00e+00 | 2.251 | 1 | 9 | 303 |
GO:0004674 | protein serine/threonine kinase activity | 1.94e-01 | 1.00e+00 | 2.227 | 1 | 6 | 308 |
GO:0005813 | centrosome | 2.04e-01 | 1.00e+00 | 2.145 | 1 | 7 | 326 |
GO:0008283 | cell proliferation | 2.06e-01 | 1.00e+00 | 2.137 | 1 | 14 | 328 |
GO:0008285 | negative regulation of cell proliferation | 2.20e-01 | 1.00e+00 | 2.031 | 1 | 10 | 353 |
GO:0046982 | protein heterodimerization activity | 2.34e-01 | 1.00e+00 | 1.924 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 2.40e-01 | 1.00e+00 | 1.883 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.46e-01 | 1.00e+00 | 1.843 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.52e-01 | 1.00e+00 | 1.804 | 1 | 24 | 413 |
GO:0043066 | negative regulation of apoptotic process | 2.58e-01 | 1.00e+00 | 1.766 | 1 | 16 | 424 |
GO:0006468 | protein phosphorylation | 2.77e-01 | 1.00e+00 | 1.649 | 1 | 10 | 460 |
GO:0042802 | identical protein binding | 2.89e-01 | 1.00e+00 | 1.575 | 1 | 19 | 484 |
GO:0016032 | viral process | 3.14e-01 | 1.00e+00 | 1.433 | 1 | 26 | 534 |
GO:0005730 | nucleolus | 3.18e-01 | 1.00e+00 | 0.814 | 2 | 66 | 1641 |
GO:0016020 | membrane | 3.28e-01 | 1.00e+00 | 0.779 | 2 | 46 | 1681 |
GO:0042803 | protein homodimerization activity | 3.44e-01 | 1.00e+00 | 1.277 | 1 | 19 | 595 |
GO:0005794 | Golgi apparatus | 3.51e-01 | 1.00e+00 | 1.241 | 1 | 9 | 610 |
GO:0007165 | signal transduction | 4.78e-01 | 1.00e+00 | 0.669 | 1 | 13 | 907 |
GO:0005615 | extracellular space | 4.97e-01 | 1.00e+00 | 0.592 | 1 | 20 | 957 |
GO:0044281 | small molecule metabolic process | 5.84e-01 | 1.00e+00 | 0.252 | 1 | 20 | 1211 |
GO:0006351 | transcription, DNA-templated | 6.52e-01 | 1.00e+00 | -0.004 | 1 | 57 | 1446 |